(NYU Langone Medical Center / New York University School of Medicine) A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease instead of seeking immediate radiation treatment or surgery.
A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease instead of seeking immediate radiation treatment or surgery.
A standard hormone supplement, used to boost energy levels in prostate cancer patients following radiotherapy, could potentially increase the chances of the cancer returning, a new study has shown.
(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of dementia than patients who receive different treatment for these malignancies, a U.S. study suggests.
(University of York) A new study at the University of York has shown that a standard hormone supplement, used to boost energy levels in prostate cancer patients following radiotherapy, could potentially increase the chances of the cancer returning.
A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth or eradicated the men’s cancers with surgery or radiation. What does this study mean for patients? Based on research we have conducted on prostate cancer decision-making, the […]
Prostate cancer patients taking testosterone-lowering drugs may be twice as likely to develop dementia. The researchers found that males who underwent androgen-deprivation therapy (ADT) had an eight percent risk of dementia within five...Show More Summary
Men being treated with prostate cancer therapies that reduce their testosterone levels are at greater risk of developing dementia within five years. Reducing testosterone levels with androgen deprivation therapy (ADT) is a common treatment...Show More Summary
Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with, research shows.
Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.
(The JAMA Network Journals) Androgen deprivation therapy is a mainstay of prostate cancer treatment. ADT has shown survival benefit in some patients but it also has been associated with some adverse health effects and a possible link to neurocognitive dysfunction.
(Stanford University Medical Center) A new retrospective study of the health records of prostate cancer patients supports an association between androgen deprivation therapy and future risk of dementia.
Reducing testosterone levels with androgen deprivation therapy, or A.D.T., more than doubles the risk of dementia.
Androgen Deprivation Therapy, a common hormone therapy to treat prostate cancer, may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported.
Parental occupation and neighborhood income influence risks for getting melanoma, breast, cervical and prostate cancers, Huntsman Cancer Institute researchers report.
(Harvard T.H. Chan School of Public Health) The smokeless tobacco product snus, used mainly in Sweden but sold in the US, may increase the risk that men with prostate cancer will die from their disease, and the risk that they'll die prematurely from any cause, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.
Ben Stiller—one of the few comedians on this side of the pond who can make me laugh—said prostate-specific antigen (PSA) testing saved his life. I suspect he wasn’t being funny. Stiller had Gleason Grade 7 localized prostate cancer. Is he right? The honest answer is that we don’t know for certain. Before I get granular, […]
(Reuters Health) - Doctors at one large U.S. medical center didn't cut back on their orders of a controversial prostate cancer test even though a government-backed panel advised against its use, according to a new study.
Arnold Palmer recently passed away, leaving an enormous legacy of golf achievements. He won 92 championships, 62 on the PGA tour starting with the Canadian Open in 1855 at age 26. He also won 18 times in foreign championships and 12Show More Summary